Trial intelligence / Profile preview

Azvudine for COVID-19 Prevention in Household Contacts

NCT05682599Phase 2Unknown

Sponsor
Henlius
Start
Jan 2023
Primary completion
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of azvudine in coronavirus disease 2019 (COVID-19), sponsored by Henlius. Status: unknown.

02

Drugs

azvudine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT05682599.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05682599.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call